Anticancer Drug

Product Details:

Our company is instrumental in the importing, manufacturing, supplying and wholesaling of optimum quality Anti Cancer Drug (PEG Grafeel PFS). This drug is processed under the guidance of expert professionals in our hygienic processing unit. To ensure the flawlessness, offered range of drugs undergo several quality checks by our efficient quality controllers. Highly demanded in the market, these are effective against cancer.

Features:

• Pure composition
• Optimum pH range
• Quick result

Details:

• PEG Filgrastim PFS
• Manufactured By: DR. Reddy''s, India
• Available As: 6mg PF

Additional Information:

• Item Code: FIL
• Pay Mode Terms: L/C (Letter of Credit),T/T (Bank Transfer),Other
• Port of Dispatch: mumbai
• Production Capacity: 5000
• Delivery Time: 7-10DAYS

Product Details:

Enriched with rich domain expertise, we are engaged in the business of trading, supplying and exporting of highly demanded Cancer Therapy Tablets.

These medicines are formulated using quality assured ingredients in compliance with FDA norms. Offered medicines are effective against soft tissue sarcoma, gastric, hepatic, malignant lymphomas, ovarian carcinoma and breast carcinoma.

Features:

Standard formulation

Precise pH

High purity

We are manufacturer and exporter of cancer therapy medicines like:

Cisplatin Injection

Carboplatin Injection

Doxorubicin Injection

Docetaxel Injection

Epirubicin Injection

Etoposide Injection

Granisetron Injection

Amifostine Injection

Oxaliplatin Injection

Cyclophosamide Antineoplastic

Dacarbazine Injection

Fludarabine Injection

Gemcitabine Injection

Methotrexate Injection

Mesna Injection

Vincristine Injection

Zolendronic Acid

Vinbiastine Injection

Docetaxel 120MG

Ifosfamide Injection

Bleomycin Injection

Cytarabine Injection

Cytosine Arabinoside Injection

Di-Sodium Pamidronate Injection

Dactinomycin Injection

Daunorubicin Injection

Product Details:

Erlotinib
Our company holds expertise in offering best quality erlotinib Tablets to our valuable customers. These drugs are widely used for the effective treatment of pancreatic and lung cancers. Driven by an intense desire to attain maximum customer satisfaction, we deliver these drugs within the promised time frame at the customers'' end.

Erlotinib hydrochloride is a drug used to treat non-small cell lung cancer (NSCLC), pancreatic cancer and several other types of cancer. It is a reversible tyrosine kinase inhibitor, which acts on the epidermal growth factor receptor (EGFR). It is marketed in the United States by Genentech and OSI Pharmaceuticals and elsewhere by Roche.MechanismErlotinib is an EGFR inhibitor. The drug follows Iressa (gefitinib), which was the first drug of this type. Erlotinib specifically targets the epidermal growth factor receptor(EGFR) tyrosine kinase, which is highly expressed and occasionally mutated in various forms of cancer. It binds in a reversible fashion to the triphosphate(ATP) binding site of the receptor. For the signal to be transmitted, two EGFR molecules need to come together to form a homodimer. These then use the molecule of ATP to trans-phosphorylate each other on tyrosine residues, which generates phosphotyrosine residues, recruiting the phosphotyrosine-binding proteins to EGFR to assemble protein complexes that transduce signal cascades to the nucleus or activate other cellular biochemical processes. By inhibiting the ATP, formation of phosphotyrosine residues in EGFR is not possible and the signal cascades are not initiated.
Clinical applicationsErlotinib has shown a survival benefit in the treatment of lung cancer in phase III trials. The SATURN study found that erlotinib added to chemotherapy improved overall survival by 19%, and improved progression-free survival (PFS) by 29%, when compared to chemotherapy alone.The U.S. Food and Drug Administration (FDA) has approved erlotinib for the treatment of locally advanced or metastatic non-small cell lung cancer that has failed at least one prior chemotherapy regimen.

Side effectsRash occurs in the majority of patients. This resembles acne and primarily involves the face and neck. It is self-limited and resolves in the majority of cases, even with continued use. Interestingly, some clinical studies have indicated a correlation between the severity of the skin reactions and increased survival though this has not been quantitatively assessed. The Journal of Clinical Oncology reported in 2004 that "cutaneous [skin] rash seems to be a surrogate marker of clinical benefit, but this finding should be confirmed in ongoing and future studies." The newsletter Lung Cancer Frontiers reported in its October 2003 issue, "Patients with moderate to severe cutaneous reactions [rashes] have a far better survival, than those with only mild reactions and much better than those with no cutaneous manifestations of drug effects."DiarrheaLoss of appetite Fatigue Rarely, interstitial pneumonitis, which is characterized by cough and increased dyspnea. This may be severe and must be considered among those patients whose breathing acutely worsens.Rarely, ingrown hairs, such as eyelashes. It has also been suggested that erlotinib can cause hearing loss. Partial hair loss (by strands, not typically in clumps)

Features

• Accurate composition
• Highly effective
• Long shelf life

Details
Erlotinib hydrochloride Tablet

Manufacturer Roche
Packing 30 Tablet

Additional Information:

• Pay Mode Terms: L/C (Letter of Credit),T/T (Bank Transfer)
• Port of Dispatch: Mumbai
• Production Capacity: 10000 Packs
• Delivery Time: 5-7 days

Product Details:

Alphalan is indicated for the palliative treatment of multiple myeloma and for the palliation of non-resectable epithelial carcinoma of the ovary.

Alphalan is a chemotherapy drug which contains melphalan, and is mainly used for treating multiple myeloma, melanoma, ovarian and breast cancer.

The medicine is an alkylating agent of the bi Schloroethylamine Type. It is useful against both resting as well as rapidly dividing tumor cells.

Alphalan is used for palliative treatment of multiple myeloma and for the palliation of non-resectable epithelial carcinoma of the ovary.

Product Details:

Owing to our rich industry experience, we are engaged in the manufacturing, supplying and exporting of utmost quality Glioblastoma Medicines.

Processed using best quality ingredients, these drugs are prescribed for the treatment of crohn''s disease, psoriasis, psoriatic arthritis, rheumatoid arthritis and scleroderma. Offered drugs minimize the growth of cancer cells in bone marrow, digestive tract, and hair follicles.

Features:

• Optimum formulation
• High purity
• Long lasting results

Details:

• Docegem -Docetaxel Injections
• Gefticare- Gefitinib 250mg Tablets
• Anastrocare-Anastrozole 1mg Tablets

Product Details:

Thalidomide Capsules Which belongs to a class of medications called immunomodulatory agents.

Thalix is used s for treating and preventing skin inflammation in patients who have moderate to severe erythema nodosum leprosum (enl: episodes of skin sores, fever, and nerve damage that occur in people with hansen''s disease

Product Details:

We are among the pioneers in the industry, engaged in offering Erlonat Tablets to our revered customers.

The offered medication is extensively used in the treatment of non-small lung cancer.

It is made available in several compositions so as to fulfill the diverse needs of the patients. Being safe and having a long shelf life, it is widely recommended by physicians.

Features:

• Safe for consumption
• Accurate composition
• Long shelf life

Indication:

• Erlonat is used for the Treatment of Non-small Cell Lung Cancer. Erlonat is used in Combination with Gemcitabine for the Treatment of Pancreatic Cancer that has spread to nearby Tissues or to Other Parts of the Body.

Available as:

• 25 Mg, 100 Mg & 150 Mg Tablets.

Manufactured by:

• Natco Pharma Ltd. (India)

Note:

• Erlonat is a prescription Drug and should be used under Proper Medical Guidance and Advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this Drug.

Additional Information:

• Item Code: 150mg
• Port of Dispatch: Mumbai
• Production Capacity: 200000
• Delivery Time: 72 Working Hours through DHL EMS
• Packaging Details: Erlonat (Erlotinib)-150mg (30 Tablets)